177 related articles for article (PubMed ID: 15702493)
1. Linking Smads and transcriptional activation.
Inman GJ
Biochem J; 2005 Feb; 386(Pt 1):e1-e3. PubMed ID: 15702493
[TBL] [Abstract][Full Text] [Related]
2. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
3. Smad regulation in TGF-beta signal transduction.
Moustakas A; Souchelnytskyi S; Heldin CH
J Cell Sci; 2001 Dec; 114(Pt 24):4359-69. PubMed ID: 11792802
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
5. The Smad3 linker region contains a transcriptional activation domain.
Wang G; Long J; Matsuura I; He D; Liu F
Biochem J; 2005 Feb; 386(Pt 1):29-34. PubMed ID: 15588252
[TBL] [Abstract][Full Text] [Related]
6. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3.
Dennler S; Huet S; Gauthier JM
Oncogene; 1999 Feb; 18(8):1643-8. PubMed ID: 10102636
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.
Mori N; Morishita M; Tsukazaki T; Giam CZ; Kumatori A; Tanaka Y; Yamamoto N
Blood; 2001 Apr; 97(7):2137-44. PubMed ID: 11264182
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta signaling by Smad proteins.
Miyazono K; ten Dijke P; Heldin CH
Adv Immunol; 2000; 75():115-57. PubMed ID: 10879283
[TBL] [Abstract][Full Text] [Related]
9. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.
Ghosh AK; Yuan W; Mori Y; Varga J
Oncogene; 2000 Jul; 19(31):3546-55. PubMed ID: 10918613
[TBL] [Abstract][Full Text] [Related]
10. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors.
Kawabata M; Inoue H; Hanyu A; Imamura T; Miyazono K
EMBO J; 1998 Jul; 17(14):4056-65. PubMed ID: 9670020
[TBL] [Abstract][Full Text] [Related]
11. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
[TBL] [Abstract][Full Text] [Related]
13. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
14. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
16. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
17. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.
Pierreux CE; Nicolás FJ; Hill CS
Mol Cell Biol; 2000 Dec; 20(23):9041-54. PubMed ID: 11074002
[TBL] [Abstract][Full Text] [Related]
19. Microtubule binding to Smads may regulate TGF beta activity.
Dong C; Li Z; Alvarez R; Feng XH; Goldschmidt-Clermont PJ
Mol Cell; 2000 Jan; 5(1):27-34. PubMed ID: 10678166
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
